Buy Soliqua SoloStar Pens Online

Soliqua SoloStar Pens combine insulin glargine and lixisenatide in a prefilled injectable pen for adults with type 2 diabetes. You can buy Soliqua Solostar Pens online, view current pricing, and choose the dose or quantity shown during ordering to match your clinician’s directions. This medicine is supplied through licensed pharmacy channels, with US delivery from Canada available for eligible orders.

Price, Dose Selection, and Ordering

Soliqua 100/33 price can vary by quantity, supply source, and the pen configuration available at the time you order. The product name refers to insulin glargine 100 units/mL and lixisenatide 33 mcg/mL in a SoloStar disposable pen. Use the strength and quantity shown during ordering, then match the pen directions to the treatment plan you received from your healthcare professional.

Many people looking at Soliqua cost are trying to plan around long-term diabetes therapy, pen needles, alcohol swabs, glucose testing supplies, and routine monitoring visits. A multi-pen carton may affect the overall cash-pay budget, but the right quantity should still reflect safe use, storage limits, and your refill schedule. If you are comparing diabetes medicines more broadly, the Diabetes Care category can help you see related treatment and supply types.

Soliqua without insurance is often searched by people managing out-of-pocket medication spending. Current pricing should be checked at the time of order because medication costs can change. Keep a record of your daily dose setting and remaining pens so refills are planned before you run low.

What Soliqua SoloStar Is Used For

Soliqua SoloStar is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is not used for type 1 diabetes or diabetic ketoacidosis. It should not be used together with another GLP-1 receptor agonist, because lixisenatide is already part of the combination.

The Soliqua insulin glargine lixisenatide pen brings two diabetes medicines into one daily injection. Insulin glargine is a long-acting basal insulin that supports background glucose control through the day and night. Lixisenatide is a GLP-1 receptor agonist, an incretin-based medicine that helps the body respond to rising glucose after meals and slows stomach emptying.

This combination may be considered when a single basal insulin or a GLP-1 medicine alone is not enough for the person’s blood sugar goals. For condition education and lifestyle context, see Type 2 Diabetes. Medication choices should reflect A1C goals, fasting glucose patterns, meal timing, kidney function, side effect history, and other medicines.

How the Soliqua 100/33 SoloStar Pen Is Usually Taken

Soliqua 100/33 pens are injected once daily within the hour before the first meal of the day. The dose is dialed on the pen as directed by the treatment plan. Do not take two doses on the same day to make up for a missed injection, and do not mix this medicine with other insulins or use it in an insulin pump.

The SoloStar pen is designed for subcutaneous injection, meaning the medicine is injected under the skin. Common injection areas include the abdomen, thigh, or upper arm. Rotate injection sites to reduce the chance of skin thickening, irritation, or uneven absorption.

Use a new sterile needle for each injection. After attaching the needle, follow the pen instructions for priming, dialing, injecting, and holding the needle in place long enough for the full dose. Remove the needle right after use and place it in an approved sharps container. Never share a Soliqua pen or needle with another person, even if the needle has been changed.

How Many Units Are in a Soliqua Pen?

Each SoloStar pen contains 3 mL of solution. The medication concentration is insulin glargine 100 units/mL and lixisenatide 33 mcg/mL. The actual number of days a pen lasts depends on the daily dose setting used for that person.

Soliqua dose settings are not the same as taking insulin glargine alone. Each dialed dose delivers a fixed amount of both insulin glargine and lixisenatide. Because the two medicines are linked in one fixed-ratio pen, dose changes should be made only according to the plan set by a healthcare professional.

Quick tip: Keep a simple log of dose setting, injection time, meals, and glucose readings so follow-up visits are more productive.

Storage, Travel, and Pen Handling

Unopened Soliqua prefilled pens should be stored as directed on the carton and official instructions, generally with refrigeration before first use. Do not freeze the pens, and do not use a pen that has been frozen. Protect the solution from heat and light, and discard pens according to the labeled in-use period after first use.

When traveling, carry pens, needles, glucose supplies, and documentation in your carry-on rather than checked luggage. A temperature-aware travel case can help protect the medicine from extremes. Orders may use prompt, express shipping when appropriate, but you should still inspect the package and follow storage instructions as soon as it arrives.

Before each injection, look at the solution through the pen window. Do not use it if the liquid appears cloudy, colored, or contains particles. For broader device education, the type 2 diabetes articles section may help you discuss injection routines, meal planning, and monitoring questions with your care team.

Side Effects, Warnings, and Monitoring

Common side effects may include nausea, diarrhea, vomiting, decreased appetite, headache, dizziness, upper respiratory symptoms, or injection-site reactions. Stomach effects are often most noticeable when starting or adjusting therapy. Staying hydrated and reporting persistent vomiting or diarrhea matters because dehydration can worsen kidney problems.

Low blood sugar can occur, especially when Soliqua is used with other medicines that lower glucose, such as sulfonylureas or additional insulin. Symptoms may include shakiness, sweating, fast heartbeat, hunger, confusion, headache, or weakness. Ask your healthcare professional how to recognize and treat hypoglycemia, and keep a fast-acting sugar source available.

Serious risks can include pancreatitis, severe allergic reactions, kidney injury, gallbladder problems, and worsening stomach-emptying disorders. Seek urgent care for severe abdominal pain that may spread to the back, swelling of the face or throat, trouble breathing, severe rash, confusion, fainting, or symptoms of very low blood sugar. People with severe gastroparesis or a prior serious allergic reaction to insulin glargine, lixisenatide, or any ingredient should discuss safer alternatives.

The lixisenatide component slows stomach emptying, which may affect absorption of some oral medicines. Timing may matter for medicines that need rapid absorption or have a narrow therapeutic window. Discuss antibiotics, thyroid medicine, blood thinners, oral contraceptives, alcohol use, kidney disease, gallbladder history, and past pancreatitis before using this treatment.

How It Compares With Lantus, Ozempic, and Other Options

Soliqua is not the same as Lantus. Lantus contains insulin glargine only, while Soliqua contains insulin glargine plus lixisenatide. A basal insulin alone may be preferred for some people, while a fixed-ratio combination may reduce the need to manage two separate injectable medicines.

Soliqua is also not the same as Ozempic. Ozempic contains semaglutide, a different GLP-1 receptor agonist, and does not contain basal insulin. Soliqua contains lixisenatide plus insulin glargine, so it addresses fasting glucose through basal insulin and post-meal response through the GLP-1 component.

People who need basal insulin without a GLP-1 component may discuss alternatives such as insulin glargine products. Broader browsing by source country is available through the Canada attribute archive, while condition-focused browsing remains in the diabetes categories. The best comparison depends on glucose patterns, tolerability, injection preferences, kidney status, and weight-related goals.

What to Expect Over Time

Blood sugar changes are usually assessed through home glucose readings and periodic A1C testing. Fasting readings may improve as the basal insulin portion is adjusted, while the lixisenatide portion helps with meal-related glucose response. Some people notice less appetite, but weight changes vary and should not be the only reason to choose this medicine.

Early stomach upset may improve with time, but ongoing nausea, repeated vomiting, dehydration, or severe abdominal pain should be reported promptly. Daily routines help: inject before the first meal, keep meal timing reasonably consistent, rotate injection sites, and track readings. Bring your pen-use questions to follow-up visits, especially if your glucose readings are often below or above target.

Why it matters: A fixed-ratio pen links both ingredients, so glucose logs help guide safe adjustments.

Questions to Ask Before Starting or Refilling

• What daily dose setting should I use, and when should I report glucose changes?
• How should I handle a missed dose if my first meal timing changes?
• Do any of my pills need to be taken at a different time?
• What symptoms of low blood sugar should my family or caregiver know?
• How should I store my pen during travel or hot weather?
• Which side effects should prompt urgent medical attention?
• How often should A1C, kidney function, and glucose logs be reviewed?

Authoritative Sources

• FDA prescribing information for Soliqua 100/33
• Health Canada product record

This content is for informational purposes only and is not a substitute for professional medical advice.